Zemaira is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare genetic condition. Zemaira is also known by its drug name, alpha1-proteinase inhibitor [human].
Zemaira is an alpha1-proteinase inhibitor, a type of molecule derived from human plasma. Zemaira is believed to work by protecting the lungs from damage.
How do I take it?
Zemaira is administered once a week as an intravenous infusion.
Zemaira comes in vial form and requires reconstitution.
The FDA-approved label for Zemaira lists commo... read more